Long-Term Safety Of Ropinirole XR In Patients With Restless Legs Syndrome
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to assess the safety and tolerability of ropinirole XR
in the long-term treatment (up to 52 weeks)of adults with RLS.